TAKEDA PHARMA (TKPYY) SEC filings
TKPYY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TKPYY overview →
No TKPYY SEC filing events in the measured window.
Nothing matched in the current window — the TKPYY overview has every event we measure for this name.
Get an email when TKPYY moves on news →Keep exploring
More TKPYY: earnings → · analyst actions → · TKPYY overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | 192 | -1.42% | 30% |
| Kezar Life Sciences, Inc. (KZR) | 192 | +0.14% | 55% |
| Arbutus Biopharma Corporation (ABUS) | 191 | +0.11% | 52% |
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.